Fundraising FoxExome Asset Management
Fund of fundsNew York · Growth–Late Stage
Find your way into Exome Asset Management
Sign up to see every warm intro you have to Exome Asset Management
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Exome Asset Management team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 2 of 2 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×1
HQs:China×1United States×1
Investments · 2 tracked
founders shown can be your intro path
Gracell Biotechnologies develops cell therapy manufacturing platforms and treatments, with a focus on CAR-T cell therapies for cancer and autoimmune diseases.
BiotechHealthtechMedical DevicesSuzhou, CN
William Wei Caoin
Co-investorsLAVLilly Asia VenturesOrbiMedPivotal Life SciencesJanus Henderson InvestorsRA Capital+3 more
Centrexion develops therapies for the treatment of pain, focusing on the design and execution of clinical trials for pain drug development.
BiotechHealthtechBaltimore, US
James N. Campbell(President, Chief Scientific Officer)inKerrie L. Brady(Executive Officer)inGregg Beloff(Executive Officer)Jeffrey B. Kindler(Chief Executive Officer)inCharles Oh(Chief Medical Officer)inSmital Shah(Acting CBO)in
Co-investorsCatalio Capital Management, LPEFung CapitalNew Enterprise Associates (NEA)Quan Capital6 Dimensions CapitalAvoro Capital Advisors
Portfolio news
latest coverage across their companiesCentrexion Therapeutics · trysignalbase.com · Mar 25, 2026
Frequently asked questions
- What stage does Exome Asset Management invest at?
- Exome Asset Management invests at the Growth, Late Stage stages.
- What sectors does Exome Asset Management focus on?
- Exome Asset Management focuses on Healthtech.
- Where is Exome Asset Management located?
- Exome Asset Management is headquartered in New York, US.
Similar investors
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.
Ascension Ventures manages capital and presents itself as an investor connected to a large health system network, referencing hundreds of acute care hospitals and a substantial employee base.
CareQuest Innovation Partners is a for-profit subsidiary of the nonprofit CareQuest Institute for Oral Health that funds, scales, and convenes solutions improving overall health through oral health.
Cross Creek is an investment firm whose senior team, working together since 2010, brings experience across both public and private markets and advises funds that invest in portfolio companies and funds.
6 Dimensions Capital is a healthcare-focused investment firm with offices in Boston, San Francisco, Hong Kong, and Shanghai. It backs healthcare startups and growth-stage companies operating in the U.S., Europe, China, Israel, and other markets, with an emphasis on life sciences businesses spanning China and the United States.